We are live on ! Find out more
MAM

Marquette Asset Management Portfolio holdings

AUM $779M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.51%
5 Year Est. Return
+57.16%
10 Year Est. Return
+244.82%
AUM
$588M
AUM Growth
+$11.7M
Cap. Flow
+$6.55M
Cap. Flow %
1.11%
Top 10 Hldgs %
76.24%
Holding
211
New
14
Increased
34
Reduced
35
Closed
18

Sector Composition

Rank Sector Weight
1 Technology 1.14%
2 Consumer Discretionary 0.87%
3 Healthcare 0.62%
4 Communication Services 0.56%
5 Industrials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TATT icon
101
TAT Technologies
TATT
$541M
$114K 0.02%
7,628
-6,258
-45% -$82.3K
OKUR
102
OnKure Therapeutics
OKUR
$166M
$111K 0.02%
7,377
TMO icon
103
Thermo Fisher Scientific
TMO
$209B
$111K 0.02%
200
KZR
104
DELISTED
Kezar Life Sciences
KZR
$107K 0.02%
17,806
+5,196
+41% +$39.5K
PMVP icon
105
PMV Pharmaceuticals
PMVP
$62.4M
$104K 0.02%
64,009
SEER icon
106
Seer Inc
SEER
$122M
$103K 0.02%
61,510
CMRX
107
DELISTED
Chimerix, Inc.
CMRX
$102K 0.02%
116,009
KRON
108
DELISTED
Kronos Bio
KRON
$99.7K 0.02%
80,369
VTI icon
109
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
$99.2K 0.02%
371
HON icon
110
Honeywell
HON
$78.9B
$98.2K 0.02%
488
-117
-19% -$22.3K
ADAP
111
DELISTED
Adaptimmune Therapeutics
ADAP
$96.1K 0.02%
98,589
ASTC icon
112
Astrotech Corp
ASTC
$14.5M
$95.3K 0.02%
10,704
WHWK
113
Whitehawk Therapeutics
WHWK
$205M
$92.8K 0.02%
63,564
+5,757
+10% +$10.7K
NXTC icon
114
NextCure
NXTC
$23.5M
$92.6K 0.02%
4,855
ACRS icon
115
Aclaris Therapeutics
ACRS
$835M
$92.4K 0.02%
83,979
BSCW icon
116
Invesco BulletShares 2032 Corporate Bond ETF
BSCW
$1.51B
$90.2K 0.02%
4,507
+41
+0.9% +$819
CKX icon
117
CKX Lands
CKX
$22.2M
$89K 0.02%
6,596
VTV icon
118
Vanguard Morningstar Value ETF
VTV
$191B
$85.7K 0.01%
534
BOLT icon
119
Bolt Biotherapeutics
BOLT
$7.59M
$85.3K 0.01%
5,690
+856
+18% +$16.9K
BSCU icon
120
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.67B
$84.9K 0.01%
5,219
+127
+2% +$2.06K
BSCV icon
121
Invesco BulletShares 2031 Corporate Bond ETF
BSCV
$1.77B
$84.8K 0.01%
5,315
+123
+2% +$1.96K
AMGN icon
122
Amgen
AMGN
$210B
$81.5K 0.01%
261
JPM icon
123
JPMorgan Chase
JPM
$950B
$80.9K 0.01%
400
USB icon
124
US Bancorp
USB
$100B
$78.7K 0.01%
1,982
MMM icon
125
3M
MMM
$93.6B
$78.5K 0.01%
768
-1,137
-60% -$111K

Similar funds

Marquette Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Marquette Asset Management held 211 positions worth $588M, up 2% from $577M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Marquette Asset Management's Q2 2024 filing shows 14 new, 34 increased, 35 reduced and 18 closed positions. Its largest new stake was JPMorgan Equity Premium Income ETF: 292,060 shares worth $16.6M. The largest sale was State Street SPDR S&P Kensho New Economies Composite ETF, an estimated $26.7M.

By sector, the portfolio is most concentrated in Technology at 1.1% of assets, up from 1% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marquette Asset Management's largest Q2 2024 buy was JPMorgan Equity Premium Income ETF: 292,060 shares worth $16.6M.
  • Marquette Asset Management added most to Schwab US Dividend Equity ETF in Q2 2024, an estimated $1.32M increase.
  • Marquette Asset Management's biggest Q2 2024 reduction was State Street SPDR S&P Kensho New Economies Composite ETF, cutting an estimated $26.7M.
  • Marquette Asset Management fully exited Overseas Shipholding Group Inc. in Q2 2024, selling an estimated $522K.
  • Marquette Asset Management's ten largest holdings make up 76% of its $588M portfolio in Q2 2024.
  • Marquette Asset Management opened 14 new positions and closed 18 in Q2 2024.
  • Marquette Asset Management's portfolio value rose 2% quarter-over-quarter to $588M.

Based on Marquette Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.